1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMAPS Canada Research Grant is sponsored by Multidisciplinary Association for Psychedelic Studies (MAPS) Canada. The MAPS Canada Research Grant supports Canadian psychedelic researchers and students across three streams: project grants, travel & professional development grants, and student grants.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Multidisciplinary Association for Psychedelic Studies – MAPS – Psychedelic Research for Psychological Healing MAPS is a nonprofit organization that provides public resources and leadership as we work together to create l e g a l r e s p o n s i b l e e v i d e n c e – b a s e d pathways to psychedelics. Attend We are a hub for psychedelic education. Register for the largest psychedelic gathering in history!
Research We incubated the world’s most advanced psychedelic-assisted therapy research . Policy Reform We advocate for the dignity and rights of all people who use drugs, free from fear and stigma. Harm Reduction Harm reduction saves lives.
Learn about safety in therapy or provide peer support through The Zendo Project . Curious about psychedelics? MAPS is your trusted source for evidence-based information about psychedelic substances and integrated treatments What every therapist needs to know.
Resources for mental and behavioral health professionals Build the movement for psychedelic medicine and policy reform. Wear, tote, and read your way through the psychedelic renaissance. Mental health is a human right.
Charting a course for the future of psychedelics Since 1986 Since 1986, MAPS has worked tirelessly to build and share the blueprint for ending psychedelic prohibition. This MAPS blueprint is being used throughout the world to take an evidence-based approach to psychedelic healing.
As a nonprofit, MAPS has relied on the support of people like you to pursue our mission, build a movement, and change the way people think about, talk about, and consume psychedelics through research, education, and advocacy. Working to end psychedelic prohibition requires transparency and perseverance. Our work relies on the support of people from all backgrounds with all types of experience and contributions to share.
Our approach is informed by our Seven Principles. We strive to embody an unwavering commitment to equity and compassion. Moreover, we are committed to a culture of curiosity and a long-term vision informed by research.
MAPS has incubated what will likely be the first psychedelic-assisted therapy to obtain government approval in the US. Thanks to our community of supporters and dedicated team, we have been able to spread this playbook widely, develop groundbreaking psychedelic education, and host the largest gathering of the Psychedelic Renaissance.
Ultimately, we aim to end drug prohibition everywhere and unlock the healing potential of psychedelics for all who seek their benefit. We envision a world where psychedelics and marijuana are safely and legally available for beneficial uses—where research is governed by rigorous scientific evaluation of their risks and benefits. Our priority is public benefit, and our approach reflects this commitment to community over profit.
Our work is intended to support the rights and dignity of all those who use these drugs free from fear and stigma.
Discover MAPS’ Published Titles Drawing it Out: Befriending the Unconscious The Way of the Psychonaut: Two-Volume Set The Secret Chief Revealed The Ultimate Journey: Consciousness and the Mystery of Death Psyche Unbound: Essays in Honor of Stanislav Grof Journal of the Psychonaut Download our Integration Guide Just enter your email in order to download our Integration Guide
According to the current listing, eligibility includes: Canadian psychedelic researchers and students. Grant types include project grants, travel & professional development grants, and student grants. Confirm the full requirements in the official notice before applying.
The current listing shows up to $5,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
MAPS Canada Research Grant is funded by Multidisciplinary Association for Psychedelic Studies (MAPS) Canada. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleARPA-H selected 13 research teams for EVIDENT, a $139.4M initiative to develop objective clinical endpoints for rapid-acting behavioral health therapies including psilocybin. At least $50M will match state psychedelic research investments under a Trump executive order.
Read articleThe April 18 executive order, ARPA-H EVIDENT initiative, and FDA priority vouchers are reshaping mental health research funding. A guide for grant seekers.
Read article